This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, L.
Right arrow Articles by Chen, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, L.
Right arrow Articles by Chen, C. H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2004, p. 663-665, Vol. 48, No. 2
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.2.663-665.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Bifunctional Anti-Human Immunodeficiency Virus Type 1 Small Molecules with Two Novel Mechanisms of Action

Li Huang,1 Xiong Yuan,1 Christopher Aiken,2 and Chin Ho Chen1*

Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710,1 Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 372322

Received 25 July 2003/ Returned for modification 25 September 2003/ Accepted 4 November 2003

A class of betulinic acid derivatives was synthesized to target two critical steps in the human immunodeficiency virus type 1 (HIV-1) replication cycle, entry and maturation. Each mechanism of HIV-1 inhibition is distinct from clinically available anti-HIV therapeutics. The viral determinants of the antientry and antimaturation activities are the bridging sheet of HIV-1 gp120 and the P24/p2 cleavage site, respectively.

* Corresponding author. Mailing address: Duke University Medical Center, Surgical Oncology Research Facility, LaSalle Street Extension, Durham, NC 27710. Phone: (919) 684-3819. Fax: (919) 684-3878. E-mail: chc{at}acpub.duke.edu.

Antimicrobial Agents and Chemotherapy, February 2004, p. 663-665, Vol. 48, No. 2
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.2.663-665.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Blair, W. S., Cao, J., Fok-Seang, J., Griffin, P., Isaacson, J., Jackson, R. L., Murray, E., Patick, A. K., Peng, Q., Perros, M., Pickford, C., Wu, H., Butler, S. L. (2009). New Small-Molecule Inhibitor Class Targeting Human Immunodeficiency Virus Type 1 Virion Maturation. Antimicrob. Agents Chemother. 53: 5080-5087 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»